Reinhard W Holl Selected Research

Glucose (Dextrose)

12/2023	BMI Z-Score (SDS) versus Calculated Body Fat Percentage: Association with Cardiometabolic Risk Factors in Obese Children and Adolescents.
7/2023	Fasting indices of glucose-insulin-metabolism across life span and prediction of glycemic deterioration in children with obesity from new diagnostic cut-offs.
2/2023	Use of Continuous Glucose Monitoring in Pump Therapy Sensor Augmented Pump or Automated Insulin Delivery in Different Age Groups (0.5 to <26 Years) With Type 1 Diabetes From 2018 to 2021: Analysis of the German/Austrian/Swiss/Luxemburg DPV Registry.
1/2023	Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.
1/2023	The association between perinatal factors and cardiometabolic risk factors in children and adolescents with overweight or obesity: A retrospective two-cohort study.
1/2023	Continuous glucose monitoring versus blood glucose monitoring for risk of severe hypoglycaemia and diabetic ketoacidosis in children, adolescents, and young adults with type 1 diabetes: a population-based study.
1/2023	Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.
1/2023	Uric acid and gamma-glutamyl-transferase in children and adolescents with obesity: Association to anthropometric measures and cardiometabolic risk markers depending on pubertal stage, sex, degree of weight loss and type of patient care: Evaluation of the adiposity patient follow-up registry.
12/2022	Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative.
10/2022	Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reinhard W Holl Research Topics

Disease

111	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2023 - 01/2003
40	Hypoglycemia (Reactive Hypoglycemia) 10/2023 - 06/2006
34	Type 2 Diabetes Mellitus (MODY) 02/2024 - 04/2008
27	Hypertension (High Blood Pressure) 12/2023 - 06/2004
22	Dyslipidemias (Dyslipidemia) 01/2022 - 02/2006
19	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 10/2023 - 05/2010
18	Obesity 02/2024 - 02/2006
15	Insulin Resistance 07/2023 - 03/2003
13	Ketosis 01/2023 - 06/2010
11	Overweight 11/2023 - 03/2005
10	Diabetes Mellitus 04/2024 - 11/2011
10	Body Weight (Weight, Body) 02/2020 - 04/2008
9	Stroke (Strokes) 01/2023 - 07/2013
9	Myocardial Infarction 01/2023 - 05/2016
8	Cystic Fibrosis (Mucoviscidosis) 01/2018 - 04/2011
7	Coma (Comas) 06/2023 - 01/2012
6	Chronic Renal Insufficiency 01/2023 - 09/2017
6	Heart Failure 01/2023 - 07/2017
5	Diabetes Complications 06/2023 - 10/2017
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 04/2013
5	Glucose Intolerance 12/2019 - 03/2003
4	Diabetic Foot 02/2024 - 02/2016
4	COVID-19 01/2023 - 01/2021
4	Weight Gain 12/2021 - 01/2003
4	Disease Progression 01/2019 - 06/2012
3	Weight Loss (Weight Reduction) 12/2023 - 02/2020
3	Thyroid Diseases (Thyroid Disease) 12/2021 - 01/2018
3	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 05/2021 - 01/2018
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2018
3	Pediatric Obesity 12/2019 - 01/2008
3	Celiac Disease (Celiac Sprue) 01/2019 - 09/2010
2	Mental Disorders (Mental Disorder) 01/2023 - 01/2016
2	Bone Fractures (Bone Fracture) 01/2023 - 12/2021
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 01/2017
2	Albuminuria 01/2023 - 12/2021
2	Hypothyroidism 08/2021 - 04/2013
2	Feeding and Eating Disorders (Eating Disorder) 01/2019 - 01/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 10/2010
2	Dementia (Dementias) 02/2016 - 07/2013
2	Hypertriglyceridemia 01/2016 - 09/2011
2	Inflammation (Inflammations) 01/2016 - 01/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024

Drug/Important Bio-Agent (IBA)

85	Insulin (Novolin)FDA Link 11/2023 - 01/2003
41	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2003
18	LipidsIBA 12/2023 - 09/2011
16	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2023 - 06/2006
15	Hemoglobins (Hemoglobin)IBA 01/2023 - 03/2005
13	Hypoglycemic Agents (Hypoglycemics)IBA 06/2023 - 01/2012
12	HDL CholesterolIBA 12/2023 - 06/2004
11	Triglycerides (Triacylglycerol)IBA 02/2024 - 06/2004
9	LDL CholesterolIBA 12/2023 - 06/2004
8	AutoantibodiesIBA 10/2023 - 06/2010
7	SodiumIBA 01/2023 - 07/2017
7	Blood Glucose (Blood Sugar)IBA 01/2023 - 04/2015
7	CholesterolIBA 05/2014 - 06/2004
5	Antihypertensive Agents (Antihypertensives)IBA 03/2023 - 02/2006
5	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 10/2010
4	HDL LipoproteinsIBA 02/2024 - 05/2014
4	Transaminases (Aminotransferases)IBA 01/2023 - 08/2013
4	Particulate MatterIBA 01/2022 - 01/2014
4	EnzymesIBA 01/2022 - 01/2015
3	LDL Lipoproteins (beta Lipoproteins)IBA 02/2024 - 05/2014
3	empagliflozinIBA 01/2023 - 07/2017
3	C-PeptideIBA 08/2022 - 01/2003
3	Sodium-Glucose Transport ProteinsIBA 01/2021 - 07/2017
3	Growth Hormone (Somatotropin)IBA 02/2019 - 10/2013
3	CarbohydratesIBA 01/2018 - 02/2014
3	oxidized low density lipoproteinIBA 05/2016 - 08/2010
2	Oral ContraceptivesIBA 01/2024 - 01/2018
2	TransferasesIBA 01/2023 - 05/2011
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 01/2020
2	Uric Acid (Urate)IBA 01/2023 - 08/2013
2	Thyroxine (Levothyroxine)FDA LinkGeneric 08/2021 - 04/2013
2	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2021 - 01/2018
2	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2020 - 07/2013
2	CreatinineIBA 01/2020 - 09/2017
2	SaltsIBA 02/2019 - 01/2018
2	Interleukin-7 (Interleukin 7)IBA 01/2019 - 01/2018
2	OzoneIBA 01/2018 - 01/2016
2	HLA-DR Antigens (HLA-DR)IBA 01/2018 - 05/2017
2	FludrocortisoneIBA 01/2018 - 02/2016
2	repaglinide (Prandin)FDA Link 01/2018 - 03/2014
2	alpha-2-HS-GlycoproteinIBA 01/2018 - 08/2015
2	Long-Acting Insulin (Insulin, Long Acting)FDA Link 07/2017 - 05/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2016 - 05/2016
2	Air Pollutants (Pollutants, Air)IBA 01/2016 - 01/2014
2	LeptinIBA 01/2016 - 01/2016
2	Antipsychotic Agents (Antipsychotics)IBA 01/2016 - 06/2015
2	fibroblast growth factor 21IBA 01/2016 - 08/2015
2	AdipokinesIBA 01/2016 - 01/2016
2	AntibodiesIBA 01/2015 - 09/2010
1	Methotrexate (Mexate)FDA LinkGeneric 04/2024
1	Antirheumatic Agents (DMARD)IBA 04/2024

Therapy/Procedure

52	Therapeutics 04/2024 - 02/2005
29	Glycemic Control 06/2023 - 02/2006
5	Length of Stay 01/2023 - 07/2013
5	Injections 01/2022 - 03/2014
3	Surgical Amputation (Amputations) 02/2024 - 01/2018
3	Bariatric Surgery 12/2023 - 11/2018
2	Drug Therapy (Chemotherapy) 10/2017 - 10/2014